EMBO Molecular Medicine (EMM) publishes breakthrough research in translational and biomedical sciences in the field of experimental medicine. We welcome studies that deepen our understanding of human disease and provide mechanistic insight and translational implications in preclinical disease models and humans. Submissions with authoritative referee reports from Review Commons or other journals are welcome and will be considered, where possible, without additional review. The journal publishes research papers as full-length Articles, short Reports, Methods and Resource articles. In addition, EMM publishes Perspectives and Reviews that target a broad and non-specialised audience, as well as News & Views, Opinions, Correspondence and Comments. Areas covered include, but are not limited to: Ageing AI in medicine Biomarkers and Molecular diagnostics Biomedical technologies Dermatology Drug discovery Early-phase human clinical studies and case reports Endocrinology and Metabolic diseases Environmental health Exposome studies Gastroenterology Gene and cell therapy Human genetics, Autoimmunity, and Rare diseases Immunology and Inflammation Infectious diseases Microbiome Mitochondrial diseases Myopathies and Musculoskeletal diseases Nephrology Neurodegeneration and Neurological diseases Oncology Ophtalmology Reproductive medicine Respiratory diseases Stem cells and Regenerative medicine Systems medicine and Clinical omics Toxicology Vascular and cardiovascular diseases Vaccinology.